FUSN - Fusion Pharmaceuticals Inc.

Oversold Signal for 06-24-2022
Oversold Stock Signal: FUSN

Stock Signal Information


Oversold Stock
Report Date: 06-24-2022
Symbol: FUSN - Fusion Pharmaceuticals Inc.
Oversold Stock Signal: FUSN

FUSN Technical Chart

Company Contact

Fusion Pharmaceuticals Inc. (FUSN)
270 Longwood Road South
Hamilton, ON
Phone: 289 799 0891
Website: http://fusionpharma.com
CEO: Dr. John F. Valliant

Company Profile

Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it is progressing its earlier-stage product candidate, FPI-1966 into clinical development for the treatment of head and neck, and bladder cancers expressing fibroblast growth factor receptor. The company was founded in 2014 and is headquartered in Hamilton, Canada.

Top Stock Signals

free stock market signals, free stock market signals, daily stock signals

About Top Stock Signals

Good stock signals have been found on this server. That is all we know.

Phone: +1 (407) 559-7228
Email: [email protected]

About Us | Newsletter | Members

Most Active
Top Gainers
Top Losers